A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Intra-arterial Tumor Treatment - Locoregional Therapy Bookmark and Share

Intra-arterial Tumor Treatment - Locoregional Therapy

What is "locoregional" therapy?
Minimally-invasive, intravascular, catheter-based therapies at targeting the individual blood vessels that directly supply tumor, using localized high-dose chemotherapy, blood-supply constricting embolic particles, and/or radioactive particles. There are many forms of locoregional, transcatheter-based therapies, with newer, increasingly effective treatment devices and regimens being developed. These therapies are considered “bridging therapy”, but are also at times employed as definitive treatment in certain situations.

Chemoembolization (TACE, Precision-TACE)
Chemoembolization is a form of locoregional therapy that specifically targets tumors by simultaneously delivering high dose local cancer killing agents, while also, blocking the blood vessels that supply the tumor (embolization). The end effect is higher local doses of the tumoricidal agent, without the typical side-effects of traditional systemic chemotherapy. Additionally, by closing the blood vessels that supply the tumor, cancer cells that may survive the chemotherapy starve resulting in eventually tumor regression.
 
Radiotherapy (Y-90)
Internal radiation therapy is another form of locoregional therapy that utilizes targeted delivery of small, radioactive particles into certain liver tumors, resulting in death of the rapidly dividing tumor cells, while preserving the relatively sturdy normal liver cells.
 
What are some common areas of treatment?
Currently, locoregional therapy is primarily being used in the setting of liver cancers, both primary and metastatic tumors.
 
What happens after the procedure?
Patients will continue to follow-up with their referring physician, as well as, the performing interventionalist post-procedure. During routine clinic visits, blood tumor markers and other surveillance imaging will be reviewed, based upon standard protocol.
 

Intra-arterial Tumor Treatment - Locoregional Therapy

Intra-arterial Tumor Treatment - Locoregional Therapy

What is "locoregional" therapy?
Minimally-invasive, intravascular, catheter-based therapies at targeting the individual blood vessels that directly supply tumor, using localized high-dose chemotherapy, blood-supply constricting embolic particles, and/or radioactive particles. There are many forms of locoregional, transcatheter-based therapies, with newer, increasingly effective treatment devices and regimens being developed. These therapies are considered “bridging therapy”, but are also at times employed as definitive treatment in certain situations.

Chemoembolization (TACE, Precision-TACE)
Chemoembolization is a form of locoregional therapy that specifically targets tumors by simultaneously delivering high dose local cancer killing agents, while also, blocking the blood vessels that supply the tumor (embolization). The end effect is higher local doses of the tumoricidal agent, without the typical side-effects of traditional systemic chemotherapy. Additionally, by closing the blood vessels that supply the tumor, cancer cells that may survive the chemotherapy starve resulting in eventually tumor regression.
 
Radiotherapy (Y-90)
Internal radiation therapy is another form of locoregional therapy that utilizes targeted delivery of small, radioactive particles into certain liver tumors, resulting in death of the rapidly dividing tumor cells, while preserving the relatively sturdy normal liver cells.
 
What are some common areas of treatment?
Currently, locoregional therapy is primarily being used in the setting of liver cancers, both primary and metastatic tumors.
 
What happens after the procedure?
Patients will continue to follow-up with their referring physician, as well as, the performing interventionalist post-procedure. During routine clinic visits, blood tumor markers and other surveillance imaging will be reviewed, based upon standard protocol.
 
Patient Care Overview

City of Hope Locations

Faces of Cancer

Meet City of Hope patients and their families.
 
 
Clinics/Treatments/Services
As a Comprehensive Cancer Center – the highest designation given by the National Cancer Institute – we are widely regarded as a leader in cancer prevention and treatment.

Cancer Expertise Matters


NEWS & UPDATES
  • It was 2009 when a City of Hope patient in her 40s learned that the cancer she had been fighting for several years had metastasized to her lungs. Her medical team ran genetic tests on the tumor, but none of the drug therapies available at the time targeted the known mutations in the tumor cells. […]
  • Acute myeloid leukemia (AML) is characterized by a rapidly-developing cancer in the myeloid line of blood cells, which is responsible for producing red blood cells, platelets and several types of white blood cells called granulocytes. Because AML grows rapidly, it can quickly crowd out normal blood cells, leadi...
  • Rachel Divine is a yoga therapist and patient leader for the Sheri & Les Biller Patient and Family Resource Center. She’s also a former City of Hope patient. When someone you know has cancer, even the word “cancer” can make you feel nervous, sleepless, depressed or more. But, as a yoga teacher for 15 ...
  •   Diagnosed with type 1 diabetes when she was 9 years old, Gina Marchini accepted the fact that she would need insulin the rest of her life. Every day, she injected herself with the lifesaving hormone. She also carefully controlled her diet and monitored the rise and fall of her blood glucose with military...
  • The defeat of cancer will require a team effort. Nowhere is this more necessary (or apparent) than in efforts to combat two of the most deadly forms of the disease  – pancreatic cancer and triple-negative breast cancer. It’s the approach City of Hope is taking with its newly launched multidisciplinary teams, br...
  • It’s a reasonable question: Why is the National Cancer Institute funding a study on preventing heart failure? The answer is reasonable as well: Rates of heart failure are drastically high among childhood cancer survivors — 15 times higher than among people the same age who were never treated for cancer. T...
  • Many teenagers take a break from academics during the summer, but not the eight high school students enrolled in the California Institute for Regenerative Medicine (CIRM) Creativity Awards program at City of Hope. They took the opportunity to obtain as much hands-on research experience as possible, learning fro...
  • About one in eight women will develop breast cancer at some point in her life. In fact, breast cancer is the most common cancer in American women, behind skin cancer. Although women can’t change some risk factors, such as genetics and the natural aging process, there are certain things they can do to lower thei...
  • As genetic testing becomes more sophisticated, doctors and their patients are finding that such tests can lead to the discovery of previously unknown cancer risks. In his practice at City of Hope, Thomas Slavin, M.D., an assistant clinical professor in the Division of Clinical Cancer Genetics, sees the full spe...
  • And the winners are … everyone in the San Gabriel Valley. The recipients of City of Hope’s first-ever Healthy Living grants have been announced, and the future is looking healthier already. In selecting San Gabriel Valley organizations to receive the grants, City of Hope’s Community Benefits Advisory Council ch...
  • Barry Leshowitz is a former City of Hope patient and a family advisor for the Sheri & Les Biller Patient and Family Resource Center. It’s been almost seven years since I checked into a local hospital in Phoenix for a hip replacement, only to be informed by the surgeon that he had canceled the surgery....
  • When it comes to science, the best graduate schools don’t just train scientists, they prepare their students for a lifetime of learning, accomplishment and positive impact on society. At City of Hope, the Irell & Manella Graduate School of Biological Sciences goes one step further – by preparing students to...
  • Cancer affects not just the cancer patient, but everyone around him or her, even after treatment is complete. The challenges can include the fear of cancer recurrence, coping with cancer’s economic impact and the struggle to achieve work-life balance post-treatment. Family members and loved ones of cancer patie...
  •   Bladder cancer facts: Bladder cancer is a disease in which malignant (cancer) cells form in the tissues of the bladder. 2015 estimates: 74,000 new cases of bladder cancer diagnosed 16,000 deaths from bladder cancer (about 11,510 in men and 4,490 in women) Risk factors for bladder cancer: Smoking: Smokers...
  • Women with ovarian cancer have questions about the most promising treatment options, revolutionary research avenues, survivorship and, of course, the potential impact on their personal lives. Now, together in one place, are experts who can provide answers. On Saturday, Sept. 12, the 2015 Ovarian Cancer Survivor...